Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.
New research links changes in platelet count and volume to aspirin nonresponsiveness in pregnant women who develop preeclampsia, offering insights into potential biomarkers for risk monitoring.
A large national study of U.S. women ages 12 to 49 found that higher levels of testosterone and sex hormone–binding globulin were linked to lower odds of metabolic syndrome, with differences observed across racial and ethnic groups.
New 2024 EULAR recommendations offer evidence-based guidance for the use of antirheumatic drugs during pregnancy, lactation, and conception planning in patients with rheumatic and musculoskeletal diseases.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The FDA has approved enflonsia, a fixed-dose monoclonal antibody, for preventing RSV lower respiratory tract disease in infants during their first season.
New research found that first-time mothers experienced substantial sleep disruption for more than 3 months after childbirth, even as total sleep time gradually recovered.